We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Medica 2024 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Advanced Liquid Logic Acquires Nanolytics

By Labmedica staff writers
Posted on 12 Mar 2007
Advanced Liquid Logic (Morrisville, NC, USA) a microfluidics "lab-on-a-chip” spinout from Duke University's Pratt School of Engineering (Durham, NC, USA), announced that it has acquired Nanolytics, Inc. The terms of the acquisition were not disclosed.

"This clearly gives us the high ground in the race for both demonstrated progress and intellectual property in this exciting new technology. The technology has huge potential for miniaturizing test equipment and performing complex tests at the point of sample collection,” said Richard West, CEO of Advanced Liquid Logic. "Not only will we benefit from Nanolytics' patents but from the continuing contributions of key Nanolytics employees as well.”

Nanolytics, founded in the late 1990s, received several million dollars in commercial and government support prior to the transaction. Michael Pollack, an early Nanolytics employee, left Nanolytics to further develop the technology at Duke University and then went on to co-found Advanced Liquid Logic in 2004. "Our own excellent team has brought us to this important milestone,” said Advanced Liquid Logic's other co-founder Vamsee Pamula. "While the technology is exciting, it takes much more than that to create a promising company with the resources to become the industry leader.”

Advanced Liquid Logic is leading the development of a new technology for micro-liquid-handling called digital microfluidics. Small droplets can be moved under direct, programmable, software control to perform complex, liquid-based testing in a palmtop-sized device. The company's primary focus is developing products for medical diagnostics and monitoring. The company has demonstrated clinical chemistry assays, immunoassays, and polymerase chain reaction (PCR) on the technology platform and is in the process of implementing DNA sequencing, analyte sorting, test multiplexing, and integrated sample preparation.


Related Links:
Advanced Liquid Logic
Duke University

Gold Member
Turnkey Packaging Solution
HLX
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Automatic Biochemistry Analyzer
Audmax 180 Evolution
New
Silver Member
Apolipoprotein A-I Assay
Apo A-I Assay

Latest Industry News

Bio-Techne and ALZpath Partner to Advance Neurodegenerative Disease Research and Treatment

Microbiologics Acquires Diagnostic Quality Controls Manufacturer SensID

Beckman Coulter Partners with BioPorto for Global Distribution of Acute Kidney Injury NGAL Tests